A strategy for selective screening of dual-target bioactive compounds against hypertrophic scar through inhibiting angiotensin II type 1 receptor while stimulating type 2 receptor from Chinese herbs
Abstract Background Cutaneous hypertrophic scar is a fibro-proliferative hard-curing disease. Recent studies have proved that antagonists of angiotensin II type 1 receptor (AT1R) and agonists of type 2 receptor (AT2R) were able to relieve hypertrophic scar. Therefore, establishing new methods to pur...
Saved in:
Main Authors: | Lejing Qu, Meizhi Jiao, Zilong Zhang, Yuanyuan Ou, Xue Zhao, Yajun Zhang, Xinfeng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Chinese Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13020-025-01065-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL PROFILE AND MANAGEMENT OF HYPERTROPHIC SCARS AT DR. SOETOMO GENERAL ACADEMIC HOSPITAL SURABAYA, INDONESIA
by: Arda Rahmanisa Perdanakusuma, et al.
Published: (2024-12-01) -
Fraxinellone-mediated targeting of cathepsin B leakage from lysosomes induces ferroptosis in fibroblasts to inhibit hypertrophic scar formation
by: Wei Xu, et al.
Published: (2025-02-01) -
Combined fractional carbon dioxide laser with long pulsed Nd:YAG laser for treatment of immature hypertrophic scar
by: Zaynab S. Keshk, et al.
Published: (2024-01-01) -
Knowledge, attitude, and practice of aesthetic medicine practitioners towards laser and/or light therapy for hypertrophic scars
by: Wenhui Yang, et al.
Published: (2025-01-01) -
Integrated analysis of ATAC-seq and RNA-seq reveals ADSCP2 regulates oxidative phosphorylation pathway in hypertrophic scar fibroblasts
by: Qian Li, et al.
Published: (2025-01-01)